Hypercalcaemia in osteogenesis imperfecta treated with pamidronate
- PMID: 9068314
- PMCID: PMC1717065
- DOI: 10.1136/adc.76.2.169
Hypercalcaemia in osteogenesis imperfecta treated with pamidronate
Abstract
The response to the bisphosphonate, pamidronate, is reported in a child with osteogenesis imperfecta who had recurrent symptomatic hypercalcaemia after immobilisation following fractures. Oral clodronate was effective in the prevention of immobilisation hypercalcaemia in the same child. The bisphosphonates may have other roles in osteogenesis imperfecta by decreasing bone turnover.
Comment in
-
Bisphosphonates in osteogenesis imperfecta.Arch Dis Child. 1997 Jul;77(1):92-3. doi: 10.1136/adc.77.1.91c. Arch Dis Child. 1997. PMID: 9279168 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical